Buy or sell SpringWorks Therapeutics stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

SpringWorks Therapeutics Stock
SpringWorks is a medicines company.
About SpringWorks Therapeutics Stock
They are a different type of therapeutic development company purpose-built for the 21st century. SpringWorks Therapeutics is on a mission to connect scientists, biopharmaceutical partners, patient groups, funders and philanthropists to deliver promising, transformative science to underserved patients. Their name symbolizes their mission-driven approach to therapeutic development—they’re springing into action to deliver treatments to people who are in urgent need.
Funding History
September 2017 | $103M |
---|
Management
President and Founder
Lara S. Sullivan
Executive Chairman
Daniel S. Lynch
Chief Financial Officer and Chief Business Officer
Saqib Islam
Press
Business Wire (press release) - Mar, 5 2018
Baltimore Business Journal - Feb, 2 2018
MedCity News - Sep, 29 2017
HIT Consultant - Sep, 27 2017
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase